Key result
Rhythm control was associated with a lower risk of 1-year all-cause mortality compared with rate control.
Why the study?
Limited data exist to guide treatment for patients with heart failure with preserved ejection fraction and atrial fibrillation, including the decision regarding rate versus rhythm control.
Does rhythm control reduce 1-year all-cause mortality compared to rate control in older patients with HFpEF and AF?
Cohort (n=15,682)
Yes
Does rhythm control reduce 1-year all-cause mortality compared to rate control in older patients with HFpEF and AF?
In older patients with HFpEF and AF, a rhythm control strategy is associated with lower 1-year all-cause mortality compared to a rate control strategy.
Answers are grounded in this paper and cite their sources.
Rhythm control was associated with lower 1-year mortality in older HFpEF-AF patients; hypothesis-generating and requires randomized confirmation before practice change.
Background Limited data exist to guide treatment for patients with heart failure with preserved ejection fraction and atrial fibrillation, including the important decision regarding rate versus rhythm control. Methods and Results We analyzed the Get With The Guidelines—Heart Failure (GWTG‐HF) registry linked to Medicare claims data from 2008 to 2014 to describe current treatments for rate versus rhythm control and subsequent outcomes in patients with heart failure with preserved ejection fraction and atrial fibrillation using inverse probability weighted analysis. Rhythm control was defined as use of an antiarrhythmic medication, cardioversion, or AF ablation or surgery. Rate control was defined as use of any combination of β‐blocker, calcium channel blocker, and digoxin without evidence of rhythm control. Among 15 682 fee‐for‐service Medicare patients, at the time of discharge, 1857 were treated with rhythm control and 13 825 with rate control, with minimal differences in baseline characteristics between groups. There was higher all‐cause death at 1 year in the rate control compared with the rhythm control group (37.5% and 30.8%, respectively, P <0.01). The lower 1‐year all‐cause death in the rhythm control group remained after risk adjustment (adjusted hazard ratio, 0.86; 95% CI , 0.75–0.98; P =0.02). Conclusions Rhythm control in patients aged 65 and older with heart failure with preserved ejection fraction and AF was associated with a lower risk of 1 year all‐cause mortality. Future prospective randomized studies are needed to explore this potential benefit.
No takes yet. Share an insight, caveat, or question.
Kelly et al. (2019) conducted a cohort in Heart failure with preserved ejection fraction and atrial fibrillation (n=15,682). Rhythm control vs. Rate control was evaluated on 1-year all-cause death (HR 0.86, 95% CI 0.75-0.98, p=0.02). Rhythm control was associated with a lower risk of 1-year all-cause mortality compared with rate control.
Synapse has enriched 10 related papers. Consider them for comparative context: